Editas Medicine Inc buy melinda
Start price
08.03.17
/
50%
€20.00
Target price
08.09.17
€24.35
Performance (%)
-9.79%
End price
08.09.17
€18.04
Summary
This prediction ended on 08.09.17 with a price of €18.04. With a performance of -9.79%, the BUY prediction for Editas Medicine Inc by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Editas Medicine Inc | -5.825% | -5.825% | -37.185% | -85.798% |
| iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
| iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
| iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
| iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by melinda for this prediction
In the thread Editas Medicine Inc diskutieren
Technologie
Editas Medizin, Inc. engagiert in der Entwicklung und Vermarktung von technology.Its Genomtechnologie editting Cluster umfasst, regelmäßig kurze Palindrom Wiederholungen (CRISPR) durchsetzt; und CRISPR-assoziierten Protein 9 (case.9) .Das Unternehmen wurde von Feng Zhang, Jennifer A. Doudna, George gegründet
(Laufzeit überschritten)
Stopped prediction by melinda for Editas Medicine Inc
Editas Medicine Inc
Start price
Target price
Perf. (%)
€29.01
25.08.20
25.08.20
€31.00
04.11.21
04.11.21
13.34%
05.11.21
05.11.21
Editas Medicine Inc
Start price
Target price
Perf. (%)
€33.75
07.03.18
07.03.18
€39.69
07.09.18
07.09.18
-19.80%
07.09.18
07.09.18
Editas Medicine Inc
Start price
Target price
Perf. (%)
€30.92
07.06.16
07.06.16
€38.79
07.12.16
07.12.16
-53.70%
07.12.16
07.12.16
Editas Medicine Inc
Start price
Target price
Perf. (%)
€31.57
01.04.16
01.04.16
€33.37
01.04.16
01.04.16
6.10%
01.04.16
01.04.16